TTKHLTCARE · Healthcare · Drug Manufacturers - General
Composite scorecard: 26/100 — Quality 33 · Valuation 32 · Momentum 0
| Share price | ₹1,015.90 |
| Market cap | ₹1,301 Cr |
| P/E ratio | 19.8 |
| P/B ratio | 1.2 |
| ROE | 6.5% |
| ROCE | 7.5% |
| Dividend yield | 1.09% |
| Book value | ₹788.98 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹854 Cr | ₹66 Cr | 2.1% |
| 2025 | ₹798 Cr | ₹82 Cr | 3.4% |
| 2024 | ₹748 Cr | ₹63 Cr | 3.3% |
| 2023 | ₹720 Cr | ₹640 Cr | 2.7% |
| 2022 | — | — | — |
TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of